You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

703 Results
Drug
Other Name(s): Zinecard®
Dec 1969
Drug
Other Name(s): Xgeva®; Wyost™
Sep 2024
Drug
Other Name(s): Perjeta®
Sep 2022
Drug
Other Name(s): Tafinlar®
Dec 1969
Drug
Other Name(s): Iclusig®
Sep 2020
Drug
Other Name(s): Darzalex®
Sep 2022
Drug
Other Name(s): Ibrance™
Dec 1969
Regimen
Cancer Type:
Sarcoma, 
Soft Tissue, 
Skin, 
Melanoma
Intent: Palliative
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Intent: Curative
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Funding:
ODB - General Benefit
    dexamethasone
Sep 2019
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Palliative
Funding:
ODB - General Benefit
    prednisone
Regimen
Cancer Type:
Central Nervous System
Intent: Adjuvant, Curative, Palliative
Funding:
ODB - General Benefit
    procarbazine
ODB - General Benefit
    lomustine
Jan 2023

Pages